Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Differences in clinical and echocardiographic parameters between paroxysmal and persistent atrial flutter in the AURUM 8 study: targets for prevention of persistent arrhythmia?

L. Lickfett, E. Mittmann-Braun, C. Weiss, S. Spencker, W. Jung, W. Haverkamp, S. Willems, T. Deneke, J. Kautzner, M. Wiedemann, J. Siebels, HF. Pitschner, E. Hoffmann, G. Hindricks, M. Zabel, E. Vester, H. Schwacke, JV. Leyen, C. Mewis, W. Bauer,...

. 2013 ; 36 (2) : 194-202. [pub] -

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, multicentrická studie, randomizované kontrolované studie, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20014897

PURPOSE: Cavotricuspid isthmus-dependent atrial flutter (AFL) can occur in a paroxysmal or persistent pattern. The aim of this study was to identify clinical, echocardiographic, and electrophysiological risk factors independently associated with persistence of AFL. METHODS: Patients of the recently published AURUM 8 study with paroxysmal versus persistent AFL were compared with respect to clinical and echocardiographic baseline characteristics as well as procedural parameters. The AURUM 8 study is a randomized, multicenter clinical trial comparing the efficacy and safety of gold versus platinum-iridium 8-mm-tip ablation. AFL was paroxysmal in 218 patients and persistent in 210 patients. RESULTS: Univariate analysis revealed that patients with persistent AFL had higher New York Heart Association class (P = 0.002), shorter time since 1st AFL episode (median 0.18 vs 0.34, P = 0.037), a higher prevalence of previous coronary artery bypass grafting surgery (17% vs 9%, P = 0.02), left ventricular hypertrophy (17% vs 8%, P = 0.005), dyspnea during AFL (P < 0.001), mitral regurgitation (P = 0.002), tricuspid regurgitation (P = 0.049), and pulmonary hypertension (P = 0.01). Palpitations during AFL were less frequent in patients with persistent AFL (P = 0.001). Multivariate analysis revealed that age, weight, AFL diagnosis after initiation of class IC or III antiarrhythmic drugs for atrial fibrillation, history of left ventricular hypertrophy, dyspnea during AFL and mitral regurgitation on echocardiography were significant independent variables associated with persistent AFL. A history of atrial fibrillation and palpitations during AFL were independently associated with paroxysmal AFL. CONCLUSIONS: We were able to identify clinical and echocardiographic risk factors associated with persistence of typical AFL. Treatment of these risk factors can potentially not only prevent the transition from paroxysmal to persistent AFL, but maybe also the development or initiation of AFL in general.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20014897
003      
CZ-PrNML
005      
20220324085036.0
007      
ta
008      
200922s2013 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1111/pace.12051 $2 doi
035    __
$a (PubMed)23379836
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Lickfett, Lars $u Department of Medicine-Cardiology, Universitätsklinikum Bonn, Bonn, Germany. lars.lickfett@ukb.uni-bonn.de
245    10
$a Differences in clinical and echocardiographic parameters between paroxysmal and persistent atrial flutter in the AURUM 8 study: targets for prevention of persistent arrhythmia? / $c L. Lickfett, E. Mittmann-Braun, C. Weiss, S. Spencker, W. Jung, W. Haverkamp, S. Willems, T. Deneke, J. Kautzner, M. Wiedemann, J. Siebels, HF. Pitschner, E. Hoffmann, G. Hindricks, M. Zabel, E. Vester, H. Schwacke, JV. Leyen, C. Mewis, W. Bauer, T. Lewalter,
520    9_
$a PURPOSE: Cavotricuspid isthmus-dependent atrial flutter (AFL) can occur in a paroxysmal or persistent pattern. The aim of this study was to identify clinical, echocardiographic, and electrophysiological risk factors independently associated with persistence of AFL. METHODS: Patients of the recently published AURUM 8 study with paroxysmal versus persistent AFL were compared with respect to clinical and echocardiographic baseline characteristics as well as procedural parameters. The AURUM 8 study is a randomized, multicenter clinical trial comparing the efficacy and safety of gold versus platinum-iridium 8-mm-tip ablation. AFL was paroxysmal in 218 patients and persistent in 210 patients. RESULTS: Univariate analysis revealed that patients with persistent AFL had higher New York Heart Association class (P = 0.002), shorter time since 1st AFL episode (median 0.18 vs 0.34, P = 0.037), a higher prevalence of previous coronary artery bypass grafting surgery (17% vs 9%, P = 0.02), left ventricular hypertrophy (17% vs 8%, P = 0.005), dyspnea during AFL (P < 0.001), mitral regurgitation (P = 0.002), tricuspid regurgitation (P = 0.049), and pulmonary hypertension (P = 0.01). Palpitations during AFL were less frequent in patients with persistent AFL (P = 0.001). Multivariate analysis revealed that age, weight, AFL diagnosis after initiation of class IC or III antiarrhythmic drugs for atrial fibrillation, history of left ventricular hypertrophy, dyspnea during AFL and mitral regurgitation on echocardiography were significant independent variables associated with persistent AFL. A history of atrial fibrillation and palpitations during AFL were independently associated with paroxysmal AFL. CONCLUSIONS: We were able to identify clinical and echocardiographic risk factors associated with persistence of typical AFL. Treatment of these risk factors can potentially not only prevent the transition from paroxysmal to persistent AFL, but maybe also the development or initiation of AFL in general.
650    _2
$a senioři $7 D000368
650    _2
$a fibrilace síní $x diagnóza $x epidemiologie $x prevence a kontrola $7 D001281
650    _2
$a flutter síní $x diagnóza $x epidemiologie $x prevence a kontrola $7 D001282
650    _2
$a chronická nemoc $7 D002908
650    _2
$a komorbidita $7 D015897
650    _2
$a echokardiografie $x statistika a číselné údaje $7 D004452
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a incidence $7 D015994
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a reprodukovatelnost výsledků $7 D015203
650    _2
$a hodnocení rizik $7 D018570
650    _2
$a senzitivita a specificita $7 D012680
651    _2
$a Česká republika $x epidemiologie $7 D018153
651    _2
$a Německo $x epidemiologie $7 D005858
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a randomizované kontrolované studie $7 D016449
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Mittmann-Braun, Erica
700    1_
$a Weiss, Christian
700    1_
$a Spencker, Sebastian
700    1_
$a Jung, Werner
700    1_
$a Haverkamp, Wilhelm $7 xx0271123
700    1_
$a Willems, Stephan
700    1_
$a Deneke, Thomas
700    1_
$a Kautzner, Josef
700    1_
$a Wiedemann, Michael
700    1_
$a Siebels, Jürgen
700    1_
$a Pitschner, Heinz F
700    1_
$a Hoffmann, Ellen
700    1_
$a Hindricks, Gerhard $7 xx0271124
700    1_
$a Zabel, Markus
700    1_
$a Vester, Ernst
700    1_
$a Schwacke, Harald
700    1_
$a Leyen, Johannes V
700    1_
$a Mewis, Christian
700    1_
$a Bauer, Wolfgang
700    1_
$a Lewalter, Thorsten
773    0_
$w MED00003671 $t Pacing and clinical electrophysiology : PACE $x 1540-8159 $g Roč. 36, č. 2 (2013), s. 194-202
856    41
$u https://pubmed.ncbi.nlm.nih.gov/23379836 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200922 $b ABA008
991    __
$a 20220324085030 $b ABA008
999    __
$a ok $b bmc $g 1567757 $s 1105057
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2013 $b 36 $c 2 $d 194-202 $e - $i 1540-8159 $m Pacing and clinical electrophysiology $n Pacing Clin Electrophysiol $x MED00003671
LZP    __
$a Pubmed-20200922

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...